The effect of darbepoetin alfa on growth, oxygenation and radioresponsiveness of a breast adenocarcinoma

Radiation Research

Volumn 165, Issue 2, 2006, Pages 192-201

  Kirkpatrick, John P ^a   Hardee, Matthew E ^a   Snyder, Stacey A ^a   Peltz, Catherine M ^a   Zhao, Yulin ^a   Brizel, David M ^a   Dewhirst, Mark W ^a   Blackwell, Kimberly L ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PIMONIDAZOLE;

ANEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST ADENOCARCINOMA; CANCER RADIOTHERAPY; CANCER TRANSPLANTATION; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; GROWTH CURVE; HEMATOCRIT; HYPOXIA; LOW DRUG DOSE; NONHUMAN; OXYGEN TENSION; OXYGENATION; PRIORITY JOURNAL; PROGNOSIS; RADIATION RESPONSE; RADIOSENSITIVITY; RAT; STAINING; SURVIVAL RATE; TUMOR GROWTH; TUMOR HYPOXIA; TUMOR VOLUME;

ADENOCARCINOMA; ANIMALS; CELL PROLIFERATION; CHEMOTHERAPY, ADJUVANT; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROPOIETIN; FEMALE; MAMMARY NEOPLASMS, ANIMAL; OXYGEN; OXYGEN CONSUMPTION; RADIATION DOSAGE; RADIATION TOLERANCE; RADIATION-SENSITIZING AGENTS; RANDOM ALLOCATION; RATS; RATS, INBRED F344; SURVIVAL RATE; TREATMENT OUTCOME;

ANIMALIA;

EID: 31444438853     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR3499.1     Document Type: Article

References (57)

1. T. G. Graeber, C. Osmanian, T. Jacks, D. E. Housman, C. J. Koch, S. W. Lowe and A. J. Giaccia, Hypoxia-mediated cells with diminished apoptotic potential in solid tumours. Nature 379, 88-91 (1996).
2. T. Y. Reynolds, S. Rockwell and P. M. Glazer, Genetic instability induced by the tumor microenvironment. Cancer Res. 56, 5754-5757 (1996).
3. R. M. Sutherland, Tumor hypoxia and gene expression-implications for malignant progression and therapy. Acta Oncol. 37, 567-574 (1998).
4. G. U. Dachs and D. J. Chaplin, Microenvironmental control of gene expression: Implications for tumor angiogenesis, progression and metastases. Semin. Radiat. Oncol. 8, 208-216 (1998).
5. L. H. Gray, A. D. Conger and M. Ebert, The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br J. Radiol. 26, 638-648 (1953).
6. W. E. Powers and L. J. Tolmach, A multicomponent x-ray survival curve for mouse lymphosarcoma cells irradiated in vivo. Nature 197, 710-711 (1963).
7. M. M. Elkind, R. W. Swain, T. Alescio, H. Sutton and W. B. Moses, Oxygen, nitrogen, recovery and radiation therapy. In Cellular Radiation Biology, pp. 442-461. Williams & Wilkins, Baltimore, 1965.
8. J. S. Bedford and J. B. Mitchell, The effect of hypoxia and radiation response of mammalian cells in culture. Br. J. Radiol. 47, 687-696 (1974).
9. M. Höckel, K. Schlenger, S. Höckel and P. Vaupel, Hypoxic tumors with low apoptotic index are highly aggressive. Cancer Res. 59, 4525-4528 (1999).
10. D. A. Fein, W. R. Lee, A. L. Hanlon, J. A. Ridge, C. J. Langer, W. J. Curran and L. R. Coia, Pretreatment hemoglobin level influences local control and survival of T1-T2 squamous cell carcinomas of the glottic larynx. J. Clin. Oncol. 13, 2077-2083 (1995).
11. M. C. Höckel, K. Schlenger, B. Aral, M. Mitze, U. Schaffer and P. Vaupel, Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res. 56, 4509-4515 (1996).
12. D. M. Brizel, S. P. Scully, J. M. Harrelson, L. J. Layfield, R. K. Dodge, H. C. Charles, T. V. Samulski, L. R. Prosnitz and M. W. Dewhirst, Radiation therapy and hyperthermia improve the oxygenation of soft tissue sarcomas. Cancer Res. 56, 5347-5350 (1996).
13. D. M. Brizel, G. S. Sibley, L. R. Prosnitz, R. L. Scher and M. W. Dewhirst, Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int. J. Radiat. Oncol. Biol. Phys. 38, 285-289 (1997).
14. M. Nordsmark, M. Overgaard and J. Overgaard, Pre-treatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother. Oncol. 41, 31-39 (1996).
15. H. Frommhold, R. Guttenberger and M. Henke, The impact of blood hemoglobin content on the outcome of radiotherapy. The Freiburg experience. Strahlenther. Onkol. 174 (Suppl. 4). 31-34 (1998).
16. J. Dunst, T. Kuhnt, H. G. Strauss, U. Krause, T. Pelz, H. Koelbl and G. Haensgen, Anemia in cervical cancers: Impact on survival, patterns of relapse, and association with hypoxia and angiogenesis. Int. J. Radiat. Oncol. Biol. Phys. 56, 778-787 (2003).
17. D. M. Brizel, R. K. Dodge, R. W. Clough and M. W. Dewhirst, Oxygenation of head and neck cancer: Changes during radiotherapy and impact on treatment outcome. Radiother. Oncol. 53, 113-117 (1999).
18. J. Gulledge and M. W. Dewhirst, Tumor oxygenation: A matter of supply and demand. Anticancer Res. 16, 741-749 (1996).
19. J. L. Gabrilove, C. S. Cleeland, R. B. Livingston, B. Sarokhan, E. Winer and L. H. Einhorn, Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: Improvements in hemoglobin and quality of life are similar to three-times-weekly dosing. J. Clin. Oncol. 19, 2875-2882 (2001).
20. L. Fallowfield, D. Gagnon, M. Zagari, D. Cella, B. Bresnahan, T. J. Littlewood, P. McNulty, G. Gorzegno and M. Freund, Epoetin Alfa Study Group, multivariate regression analyses of data from a randomized, double-blind, placebo-controlled study confirm quality of life benefit of epoetin alfa in patients receiving non-platinum chemotherapy. Br. J. Cancer 87, 1341-1353 (2002).
21. J. C. Egric and J. K. Browne, Development and characterization of novel crythropoiesis stimulating protein (NESP). Br. J. Cancer 84 (Suppl. 1), 3-10 (2001).
22. J. Vansteenkiste, R. Pirker, B. Massuti, F. Barata, A. Font, M. Fiegl, S. Siena, J. Gateley, D. Tomita and J. Musil, Aranesp 980297 Study Group, double-blind, placebo-controlled, randomized phase III trial of darbepoetin alfa in lung cancer patients receiving chemotherapy. J. Natl. Cancer Inst. 94, 1211-1220 (2002).
23. J. C. Egrie, E. Dwyer, J. K. Browne, A. Hitz and M. A. Lykos, Darbepoetin alfa has a longer circulating half-life and greater in vivo potency than recombinant human erythropoietin. Exp. Hematol. 31, 290-299 (2003).
24. B. Joiner, V. K. Hirst, S. R. McKeown, J. J. McAleer and D. G. Hirst, The effect of recombinant human erythropoietin treatment on tumour radiosensitivity and cancer-associated anaemia in the mouse. Br. J. Cancer 68, 720-726 (1993).
25. O. Thews, D. K. Kelleher and P. Vaupel, Erythropoietin restores the anemia-induced reduction in cyclophosphamide cytotoxicity in rat tumors. Cancer Res. 61, 1358-1361 (2001).
26. O. Thews, R. Koenig, D. K. Kelleher, J. Kutzner and P. Vaupel, Enhanced radiosensitivity in experimental tumours following erythropoietin treatment of chemotherapy-induced anaemia. Br. J. Cancer 78, 752-756 (1998).
27. S. Pinel, M. Barberi-Heyob, E. Cohen-Jonathan, J. L. Merlin, C. Delmas, F. Plenat and P. Chastagner, Erythropoietin-induced reduction of hypoxia before and during fractionated irradiation contributes to improvement of radioresponse in human glioma xenografts. Int. J. Radiat. Oncol. Biol. Phys. 59, 250-259 (2004).
28. G. Acs, P. J. Zhang, C. M. McGrath, P. Acs, J. McBroom, A. Mohyeldin, S. Liu, H. Lu and A. Verma, Hypoxia-inducible erythropoietin signaling in squamous dysphasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression. Am. J. Pathol. 162, 1789-1806 (2003).
29. G. Acs, P. Acs, S. M. Beckwith, R. L. Pitts, E. Clements, K. Wong and A. Verma, Erythropoietin and erythropoietin receptor expression in human cancer. Cancer Res. 61, 3561-3565 (2001).
30. Y. Yasuda, Y. Fujita, T. Matsuo, S. Koinuma, S. Hara, A. Tazaki, M. Onozaki, M. Hashimoto, T. Musha and H. Utsumi, Erythropoietin regulates tumour growth of human malignancies. Carcinogenesis 24, 1021-1029 (2003).
31. W. Jelkmann, Molecular biology of erythropoietin. Intern. Med. 43, 649-659 (2004).
32. B. Leyland-Jones, Breast cancer trial with erythropoietin terminated unexpectedly. Lancet Oncol. 4, 459-460 (2003).
33. M. Henke, R. Laszig, C. Rube, U. Schafer, K. D. Haase, B. Schilcher, S. Mose, K. T. Beer, U. Burger and H. Frommhold, Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: Randomised, double blind, placebo-controlled trial. Lancet 362, 1255-1260 (2003).
34. M. Machtay, T. Pajak, M. Suntharalingam, D. Hershock, D. C. Stripp, A. Cmelak, G. Shenouda, G. Schulsinger and K. Fu, Definitive radiotherapy ± erythropoietin for squamous cell carcinoma of the head and neck: Preliminary report of RTOG 99-03. Int. J. Radiat. Oncol. Biol. Phys. 60, S132 (2004). [abstract]
35. J. Bohlius, S. Langensiepen, G. Schwarzer, J. Seidenfeld, M. Piper, C. Bennett and A. Engert, Recombinant human erythropoietin and overall survival in cancer patients: Results of a comprehensive meta-analysis. J Natl. Cancer Inst. 97, 489-498 (2005).
36. T. W. Secomb, R. Hsu, E. T. Ong, J. F. Gross and M. W. Dewhirst, Analysis of the effects of oxygen supply and demand on hypoxic fraction in tumors. Acta Oncol. 34, 313-316 (1995).
37. 2 in tumors in response to carbogen breathing. Int. J. Radiat. Oncol. Biol. Phys. 42, 855-859 (1998).
38. R. D. Braun, J. L. Lanzen, S. A. Snyder and M. W. Dewhirst, Comparison of tumor and normal tissue oxygen tension measurements using OxyLite or microelectrodes in rodents. Am. J. Physiol. Heart Circ. Physiol. 280, H2533-H2544 (2001).
39. K. L. Blackwell, J. P. Kirkpatrick, S. A. Snyder, G. Broadwater, F. Farrell, L. Jolliffe, D. M. Brizel and M. W. Dewhirst, Human recombinant erythropoietin significantly improves tumor oxygenation independent of its effects on hemoglobin. Cancer Res. 63, 6162-6165 (2003).
40. R. E. Durand and J. A. Raleigh, Identification of nonproliferating but viable hypoxic tumor cells in vivo. Cancer Res. 58, 3547-3550 (1998).
41. J. A. Raleigh, S. C. Chou, G. E. Arteel and M. R. Horsman, Comparisons among pimonidazole binding, oxygen electrode measurements, and radiation response in C3H mouse tumors. Radiat. Res. 151, 580-589 (1999).
42. P. F. Rijken, H. J. Bernsen, J. P. Peters, R. J. Hodgkiss, J. A. Raleigh and A. J. van der Kogel, Spatial relationship between hypoxia and the (perfused) vascular network in a human glioma xenograft: A quantitative multi-parameter analysis. Int. J. Radiat. Oncol. Biol. Phys. 48, 571-582 (2000).
43. J. A. Raleigh, S. C. Chou, E. L. Bono, D. E. Thrall and M. A. Varia, Semiquantitative immunohistochemical analysis for hypoxia in human tumors. Int. J. Radiat. Oncol. Biol. Phys. 49, 569-574 (2001).
44. W. H. Kruskal and W. A. Wallis, Use of ranks in one-criterion variance analysis. J. Am. Stat. Assoc. 47, 583-621 (1952).
45. E. L. Kaplan and P. Meier, Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53, 457-481 (1958).
46. N. Mantel and W. Haenszel, Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl. Cancer Inst. 22, 718-748 (1958).
47. S. Shan, B. Sorg and M. W. Dewhirst, A novel rodent mammary window of orthotopic breast cancer for intravital microscopy. Microvasc. Res. 65, 109-117 (2003).
48. A. R. Pries, T. W. Secomb, T. Gessner, M. B. Sperandio, J. F. Gross and P Gaehtgens, Resistance to blood flow in microvessels in vivo. Circ. Res. 75, 904-915 (1994).
49. E. J. Hall, Radiobiology for the Radiologist, 5th ed. Lippincott, Williams & Wilkins, Philadelphia, 2000.
50. 2 on tumor radiosensitivity. Int. J Radiat. Oncol. Biol. Phys. 59, 822-833 (2004).
51. D. M. Brizel, S. Lin, J. L. Johnson, J. Brooks, M. W. Dewhirst and C. A. Piantadosi, The mechanisms by which hyperbaric oxygen and carbogen improve tumour oxygenation. Br. J. Cancer 72, 1120-1124 (1995).
52. D. M. Brizel, W. D. Hage, R. K. Dodge, M. T. Munley, C. A. Piantadosi and M. W. Dewhirst, Hyperbaric oxygen improves tumor radiation response significantly more than carbogen/nicotinamide. Radiat. Res. 147, 715-720 (1997).
53. J. H. Barbee and G. R. Cokelet, The Fahraeus effect. Microvasc. Res. 3, 6-16 (1971).
54. B. Klitzman and B. R. Duling, Microvascular hematocrit and red cell How in resting and contracting striated muscle. Am. J. Physiol. 237, 481-490 (1979).
55. H. H. Lipowsky and J. C. Firrell, Microvascular hemodynamics during systemic hemodilution and hemoconcentration. Am. J. Physiol. 250, 908-922 (1986).
56. A. J. Fisher, N. W. Schrader and B. Klitzman, Effects of chronic hypoxia on capillary flow and hematocrit in rat skeletal muscle. Am. J. Physiol. 26, 1877-1883 (1992).
57. T. Wun, L. Law, D. Harvey, B. Sieracki, S. A. Scudder and J. K. Ryu, Increased incidence of symptomatic venous thrombosis in patients with cervical carcinoma treated with concurrent chemotherapy, radiation, and erythropoietin. Cancer 98, 1514-1520 (2003).